For the Inventor, By the Inventor

Enter assignee name

Miami, FL, United States of America

Curna, Inc.

USPTO Granted Patents = 111

% Expired Patents = 36.9

CIPO Patents = 4

EPO Patents = 51

Forward Citations = 179

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Joseph Collard (110 out of 112 patents)

Olga Khorkova Sherman (110 out of 111 patents)

Carlos Coito (26 out of 26 patents)

4. Belinda De Leon (5 out of 5 patents)

5. Jane Hsiao (3 out of 5 patents)

6. Gang Shen (3 out of 3 patents)

7. Mohammad Ali Faghihi (1 out of 1 patent)

8. Olga Khorkova (1 patent)

9. Jane H Hsiao (0 patent)

10. Shen Gang (0 patent)

Core Competencies:

Gene Therapy

Tumor Suppressor Gene

Sirtuin

Vascular Endothelial Growth Factor

Antisense Transcript

Lipid Transport

Collagen

Erythropoietin

Adiponectin

Sodium Channel

Neurotrophic Factor

Transcription Factor

111 patents: Sort by Forward Citations

1. 11697814 - Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene (2023-07-11),

2. 11408004 - Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT) (2022-08-09),

3. 11390868 - Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity (2022-07-19),

4. 11339394 - Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene (2022-05-24),

5. 10995334 - Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2 (2021-05-04),

6. 10934546 - Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT) (2021-03-02),

7. 10876117 - Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene (2020-12-29),

8. 10793857 - Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA (2020-10-06),

9. 10696966 - Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG (2020-06-30),

10. 10604755 - Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene (2020-03-31),

11. 10583128 - Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small molecules (2020-03-10),

12. 10519448 - Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF (2019-12-31),

13. 10487327 - Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor (2019-11-26),

14. 10465192 - Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1 (2019-11-05),

15. 10450567 - Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene (2019-10-22),

CURNA, INC. is a global technology company specializing in advanced data analytics and artificial intelligence solutions. Our cutting-edge products and services aim to empower businesses by leveraging data-driven insights and optimizing decision-making processes. With a focus on innovation, research, and collaboration, we strive to enable organizations to unlock the full potential of their data and drive growth in the digital era.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

111 Patents

#7 in Miami, FL

#80 in Florida

#3,451 in US

#7,097 in the World

Miami, FL, United States of America

Curna, Inc.

Forward Citations = 179

7 inventors:

Joseph Collard (110 out of 112 patents)

Olga Khorkova Sherman (110 out of 111 patents)

Carlos Coito (26 out of 26 patents)

4. Belinda De Leon (5 out of 5 patents)

5. Jane Hsiao (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…